Tag: Cancer: Leukemia

Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy

3-year-old patients did not differ from 4-year-olds in terms of ability to perform or complete testing

Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients

Overall remission occurred in 77 percent of patients in a cohort with morphologic disease

However, risk for hospitalization no higher for COVID-19 in these patients

Findings seen even for exposure below the U.S. Environmental Protection Agency guidelines

Patients who are measurable residual disease-negative at end of first consolidation do not need subsequent MRD measurements

Of patients who died during observation, median of 56 percent of time between diagnosis and death spent in hospital

Patients in low ACS10 score group have significantly improved survival with clofarabine+cytarabine treatment

Improved overall survival and three-year relapse-free survival seen with blinatumomab plus chemo for adult patients